Patents Assigned to Eve Pharma Ltd.
  • PH-DEPENDENT VAGINAL COMPOSITIONS AND METHODS OF TREATMENT OF VAGINAL DISORDERS
    Publication number: 20210283052
    Abstract: The present invention provides a pH dependent vaginal composition delivering a therapeutically effective amount of at least one active essentially at a pH above 4.5. The composition provides a diagnostic visual pH indication of the presence of vulvovaginitis at pH above 4.5. In the absence of such indication, the treatment may be discontinued. Another visual signal is the retrieval of the unchanged composition, which also points to a normal pH at or below 4.5 and absence of vulvovaginitis.
    Type: Application
    Filed: April 5, 2021
    Publication date: September 16, 2021
    Applicant: EVE PHARMA LTD.
    Inventors: Eran Eilat, Stephen Cherkez
  • Methods of treatment of vaginosis and vulvovaginitis
    Patent number: 10987306
    Abstract: The present invention provides a pH dependent vaginal composition delivering a therapeutically effective amount of at least one active essentially at a pH above 4.5. The composition provides a diagnostic visual pH indication of the presence of vulvovaginitis at pH above 4.5. In the absence of such indication, the treatment may be discontinued. Another visual signal is the retrieval of the unchanged composition, which also points to a normal pH at or below 4.5 and absence of vulvovaginitis.
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: April 27, 2021
    Assignee: Eve Pharma Ltd.
    Inventors: Eran Eilat, Stephen Cherkez